Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-315996
Filing Date
2020-12-11
Accepted
2020-12-11 17:13:52
Documents
2
Period of Report
2020-12-11

Document Format Files

Seq Description Document Type Size
1 6-K d28560d6k.htm 6-K 14560
2 EX-1.1 d28560dex11.htm EX-1.1 353113
  Complete submission text file 0001193125-20-315996.txt   368646
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 201384370
SIC: 2834 Pharmaceutical Preparations